IMMPRAIM Trademark

Trademark Overview


On Wednesday, May 10, 2023, a trademark application was filed for IMMPRAIM with the United States Patent and Trademark Office. The USPTO has given the IMMPRAIM trademark a serial number of 97929125. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, December 17, 2024. This trademark is owned by Immunocore Limited. The IMMPRAIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
immpraim

General Information


Serial Number97929125
Word MarkIMMPRAIM
Filing DateWednesday, May 10, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, December 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunocore Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Party NameImmunocore Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Trademark Events


Event DateEvent Description
Monday, February 5, 2024SUSPENSION LETTER WRITTEN
Monday, February 5, 2024LETTER OF SUSPENSION E-MAILED
Monday, February 5, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 22, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, May 13, 2023NEW APPLICATION ENTERED
Thursday, June 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 5, 2024ASSIGNED TO EXAMINER
Wednesday, September 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2024ASSIGNED TO LIE
Friday, September 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED